Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
Quick Stats
Jan 30, 202667.6
AI Score
BUY4.26
Volume Ratio
Mar 16, 2026
Next Earnings
16
+ve Days (30d)
13
-ve Days (30d)
PLX Stock Summary
Last updated Jan 30, 2026
PLX is currently trading at $2.34, positioned above its 200-day moving average of $1.89, indicating a long-term uptrend. The stock has a 52-week range of $1.32 to $3.1.
Technical Analysis: The 50-day moving average stands at $1.87, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 73.124, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.312, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates PLX at 67.6/100 with a BUY recommendation.
PLX (Protalix BioTherapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 73.124 |
| CMF (20) | 0.312 |
| ROC (10) | 13.592 |
| ADX (14) | 29.464 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.078 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -11.568 |
| MFI (14) | 55.927 |
PLX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PLX Price vs Max Options Open Interest
PLX Max Change In Options Open Interest
PLX Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PLX Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PLX Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PLX Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Protalix BioTherapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
PLX Moving Averages Analysis
Protalix BioTherapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Protalix BioTherapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
PLX (Protalix BioTherapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 2.09 |
| 20 | 2.02 |
| 30 | 1.94 |
| 50 | 1.87 |
| 100 | 2.01 |
| 200 | 1.89 |
PLX Fundamental Analysis
| P/E (Forward) | 11.8343 |
| P/E (Trailing) | 26 |
| Market Cap ($) | 188.2 million |
| Earnings/Share ($) | 0.09 |
| Net Proft Margin (%) | 0.0872 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.025 |
| EPS Estimate Next Year ($) | 0.175 |
| WallStreet Target Price ($) | 11 |
| Most Recent Quarter |